CY2007010I2 - Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου - Google Patents

Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου

Info

Publication number
CY2007010I2
CY2007010I2 CY200700010C CY2007010C CY2007010I2 CY 2007010 I2 CY2007010 I2 CY 2007010I2 CY 200700010 C CY200700010 C CY 200700010C CY 2007010 C CY2007010 C CY 2007010C CY 2007010 I2 CY2007010 I2 CY 2007010I2
Authority
CY
Cyprus
Prior art keywords
virus
pamma
disassembled
particles
human
Prior art date
Application number
CY200700010C
Other languages
English (en)
Other versions
CY2007010I1 (el
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26824774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2007010(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of CY2007010I1 publication Critical patent/CY2007010I1/el
Publication of CY2007010I2 publication Critical patent/CY2007010I2/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CY200700010C 1999-03-26 2007-03-16 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου CY2007010I2 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12652899P 1999-03-26 1999-03-26
US09/524,624 US6245568B1 (en) 1999-03-26 2000-03-13 Human papilloma virus vaccine with disassembled and reassembled virus-like particles
PCT/US2000/007595 WO2000057906A1 (en) 1999-03-26 2000-03-22 Human papillomavirus vaccine with disassembled and reassembled virus-like particles

Publications (2)

Publication Number Publication Date
CY2007010I1 CY2007010I1 (el) 2009-11-04
CY2007010I2 true CY2007010I2 (el) 2009-11-04

Family

ID=26824774

Family Applications (4)

Application Number Title Priority Date Filing Date
CY20061101649T CY1105779T1 (el) 1999-03-26 2006-11-14 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου
CY200700008C CY2007008I2 (el) 1999-03-26 2007-03-16 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου
CY2007009C CY2007009I2 (el) 1999-03-26 2007-03-16 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου
CY200700010C CY2007010I2 (el) 1999-03-26 2007-03-16 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου

Family Applications Before (3)

Application Number Title Priority Date Filing Date
CY20061101649T CY1105779T1 (el) 1999-03-26 2006-11-14 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου
CY200700008C CY2007008I2 (el) 1999-03-26 2007-03-16 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου
CY2007009C CY2007009I2 (el) 1999-03-26 2007-03-16 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου

Country Status (19)

Country Link
US (2) US6245568B1 (el)
EP (1) EP1165126B1 (el)
JP (1) JP4594534B2 (el)
KR (1) KR20020013516A (el)
AR (1) AR023166A1 (el)
AT (1) ATE339222T1 (el)
AU (1) AU778937B2 (el)
CA (1) CA2368391C (el)
CY (4) CY1105779T1 (el)
DE (4) DE122007000034I1 (el)
DK (1) DK1165126T3 (el)
ES (1) ES2270822T3 (el)
FR (1) FR07C0026I2 (el)
LT (1) LTC1165126I2 (el)
LU (3) LU91327I2 (el)
NL (3) NL300269I2 (el)
PT (1) PT1165126E (el)
SI (1) SI1165126T1 (el)
WO (1) WO2000057906A1 (el)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351533B2 (en) 1997-09-05 2008-04-01 Medimmune, Inc. In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents
US6962777B1 (en) * 1997-09-05 2005-11-08 Medimmune, Inc. In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps), homogeneous vlp and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents
WO2001042780A1 (en) * 1999-12-09 2001-06-14 Medimmune, Inc. IN VITRO METHOD FOR DISASSEMBLY/REASSEMBLY OF PAPILLOMAVIRUS VIRUS-LIKE PARTICLES (VLPs)
EP1409013B1 (en) * 2001-07-26 2009-11-18 Novartis Vaccines and Diagnostics S.r.l. Vaccines comprising aluminium adjuvants and histidine
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
DE10137102A1 (de) * 2001-07-30 2003-02-27 Deutsches Krebsforsch Polyvalente Vakzine gegen durch Papillomaviren verursachte Erkrankungen, Verfahren zu deren Herstellung und deren Verwendung
US20060073530A1 (en) * 2001-08-15 2006-04-06 Olaf Schneewind Methods and compositions involving sortase B
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
US7041500B2 (en) * 2002-02-14 2006-05-09 Novavax, Inc. Insect cell line
GB0206359D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
GB0206360D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
DE10237639A1 (de) * 2002-08-13 2004-02-26 Martin-Luther-Universität Halle-Wittenberg Verfahren zur Herstellung von virusanalogen Partikeln durch in vitro-Assemblierung von Kapsomeren oder von Kapsomeren, an die biologisch aktive Makromoleküle gebunden sind, bei gleichzeitiger Verpackung der Makromoleküle
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
MXPA05004528A (es) 2002-11-01 2005-07-26 Glaxosmithkline Biolog Sa Composicion inmunogenica.
KR101361769B1 (ko) 2002-12-20 2014-02-10 글락소스미스클라인 바이오로지칼즈 에스.에이. Ｈｐｖ-16 ｌ1 ｖｌｐ 및 ｈｐｖ-18 ｌ1 ｖｌｐ 백신
US7858098B2 (en) * 2002-12-20 2010-12-28 Glaxosmithkline Biologicals, S.A. Vaccine
EP1785433A4 (en) * 2004-07-01 2008-10-01 Tokyo Inst Tech VIRAL PARTICLE-LIKE CONSTRUCTION AND PROCESS FOR FORMING THE SAME IN PHYSIOLOGICAL CONDITIONS
MX2007008777A (es) * 2005-01-25 2007-10-23 Wyeth Res Ireland Ltd Metodo para diafiltracion.
EP1907537A4 (en) * 2005-07-14 2010-11-10 Mayo Foundation Paramyxoviridae VIRUS PREPARATIONS
JPWO2007020871A1 (ja) * 2005-08-12 2009-02-26 アステラス製薬株式会社 デプシペプチド含有注射液
WO2007027076A1 (es) * 2005-09-01 2007-03-08 Nuno Ayala Jose Luis Formula estabilizadora de vacunas con antígenos vivos para su uso en sistemas de vacunación masiva
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
EP2024520B1 (en) * 2006-05-11 2014-03-05 Becton, Dickinson and Company Method of protein extraction from cells
US9207240B2 (en) * 2007-11-14 2015-12-08 Arbor Vita Corporation Method of efficient extraction of protein from cells
US8420128B2 (en) * 2008-03-31 2013-04-16 Morinaga Milk Industry Co., Ltd. Method of imparting heat resistance to lactoferrin
BR112012004699B1 (pt) * 2009-09-03 2019-10-15 Becton, Dickinson And Company Métodos, composições e kits para lise química direta
RU2580620C2 (ru) 2010-08-23 2016-04-10 ВАЙЕТ ЭлЭлСи СТАБИЛЬНЫЕ КОМПОЗИЦИИ АНТИГЕНОВ Neisseria meningitidis rLP2086
WO2012032489A1 (en) 2010-09-10 2012-03-15 Wyeth Llc Non-lipidated variants of neisseria meningitidis orf2086 antigens
CA2865745C (en) 2012-03-09 2018-01-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
WO2013139744A1 (en) 2012-03-18 2013-09-26 Glaxosmithkline Biologicals S.A. Method of vaccination against human papillomavirus
KR101559622B1 (ko) * 2012-07-30 2015-10-13 중앙대학교 산학협력단 인유두종바이러스 바이러스 유사입자의 고효율 정제방법
US9802987B2 (en) 2013-03-08 2017-10-31 Pfizer Inc. Immunogenic fusion polypeptides
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
AU2016221318B2 (en) 2015-02-19 2020-06-25 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
US10183070B2 (en) 2017-01-31 2019-01-22 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
WO2018152505A1 (en) 2017-02-17 2018-08-23 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Efficient cell free production of papillomavirus gene transfer vectors
JP7432506B2 (ja) 2017-10-30 2024-02-16 武田薬品工業株式会社 脂質エンベロープウイルスを不活化するための環境適合性の界面活性剤
EP4034157A1 (en) 2019-09-27 2022-08-03 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
CN110987571A (zh) * 2019-12-31 2020-04-10 广州金域医学检验中心有限公司 一种单克隆多聚体m蛋白解聚方法
CN111812313B (zh) * 2020-06-22 2021-10-08 北京生物制品研究所有限责任公司 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69841708D1 (de) * 1997-02-06 2010-07-22 Merck Sharp & Dohme Thimerosal-freie konservierungsmittel für impfstoffe
IL132201A0 (en) 1997-04-08 2001-03-19 Merck & Co Inc Stabilized human papillomavirus formulations
WO1999001557A1 (en) 1997-07-03 1999-01-14 University Of Colorado, University Technology Corporation Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy

Also Published As

Publication number Publication date
EP1165126B1 (en) 2006-09-13
JP4594534B2 (ja) 2010-12-08
FR07C0026I1 (el) 2007-04-27
LTPA2007002I1 (lt) 2020-03-25
ES2270822T3 (es) 2007-04-16
EP1165126A1 (en) 2002-01-02
LU91326I9 (el) 2018-12-31
FR07C0026I2 (fr) 2012-08-03
LU91328I9 (el) 2019-03-01
DE122007000034I1 (de) 2007-08-09
AU3909300A (en) 2000-10-16
ATE339222T1 (de) 2006-10-15
CA2368391C (en) 2011-06-07
NL300269I1 (nl) 2007-05-01
KR20020013516A (ko) 2002-02-20
AR023166A1 (es) 2002-09-04
AU778937B2 (en) 2004-12-23
LTC1165126I2 (lt) 2020-04-27
DE60030698D1 (de) 2006-10-26
LU91326I2 (fr) 2007-05-14
WO2000057906A1 (en) 2000-10-05
DK1165126T3 (da) 2007-01-08
CY2007008I1 (el) 2009-11-04
CY2007009I1 (el) 2010-07-28
US20010021385A1 (en) 2001-09-13
DE122007000033I1 (de) 2007-08-09
NL300268I1 (nl) 2007-05-01
NL300269I2 (nl) 2008-07-01
US6245568B1 (en) 2001-06-12
LU91327I9 (el) 2019-03-01
CY2007010I1 (el) 2009-11-04
CA2368391A1 (en) 2000-10-05
CY1105779T1 (el) 2010-07-28
LU91327I2 (fr) 2007-05-14
JP2002540167A (ja) 2002-11-26
DE60030698T2 (de) 2007-07-19
CY2007008I2 (el) 2009-11-04
LU91328I2 (fr) 2007-05-14
NL300270I1 (nl) 2007-05-01
PT1165126E (pt) 2006-12-29
SI1165126T1 (sl) 2006-12-31
DE122007000032I1 (de) 2007-08-09
CY2007009I2 (el) 2010-07-28

Similar Documents

Publication Publication Date Title
CY2007008I1 (el) Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου
EP1307130A4 (en) VACCINE AGAINST THE VIRUS OF HUMAN IMMUNODEFICIENCY
ATE414533T1 (de) Impfstoff gegen hbv und hpv
DE60024893D1 (de) Impfstoff gegen HPV
DE60040727D1 (de) Menschliche papillomavirus impfstoff-formulierungen
EE200100568A (et) 6-alkenüül-, 6-alkünüül- ja 6-epoksüepotilooni derivaadid, nende valmistamismeetod ja kasutamine farmatseutilistes preparaatides
CY2016021I1 (el) Στελεχη ιων για την ογκολυτικη θεραπεια του καρκινου
NO20004104L (no) Preparater omfattende virus og fremgangsmater for konsentrering av viruspreparater
ATE287728T1 (de) Adjuvierte rekombinante lebendimpfstoffe gegen influenza- oder herpesviren
DE60038166D1 (de) Impfstoff gegen bakterielle antigene
CY2013001I1 (el) Nεα παραγωγα κινουκλιδινης και ιατρικα σκευασματα που τα πepιεχουν
PT1169339E (pt) Peptidos macrociclicos activos contra o virus da hepatite c
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
DK1071407T3 (da) Lipofile mikropartikler indeholdende et proteinlægemiddel eller et antigen og formulering omhandlende samme
MA25489A1 (fr) Vaccins
FR2850377B1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
EP1575601A4 (en) RECOMBINANT VACCINE VIRUSES EXPRESSING IL-15, AND METHOD OF USE THEREOF
MA27233A1 (fr) Derives de piperazinylacylpiperidine, leur preparation et leur application en therapeutique
NO20022021D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
EP1185545A4 (en) CD4-INDEPENDENT HIV ENVELOPE PROTEINS FOR USE AS VACCINES AND THERAPEUTIC AGENTS
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
EP1274305A4 (en) AID OF THE AIDS VIRUS AND VACCINE
ATE437656T1 (de) Impfstoff gegen das maul- und klauensäure-virus
ATE391767T1 (de) Geflügelkrankheit verursachendes bakterium und daraus stammender impfstoff
FR2862967B1 (fr) Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique